Skip to main content
. 2017 Jun 22;6(7):1563–1572. doi: 10.1002/cam4.1121

Figure 1.

Figure 1

Selection and disposition of the study subjects. EGFR‐TKIs, epidermal growth factor receptor‐tyrosine kinase inhibitors.